SARS-CoV-2 does not infect pigs, but this has to be verified regularlyArticle Published on 2022-09-012022-11-16 Journal: Xenotransplantation [Category] SARS, 변종, [키워드] appear China circulating close contact coronavirus CoV COVID-19 Cross-species transmission diagnostic test Donor event Geographic difference global pandemic humans infect infected with SARS-CoV-2 Infection infections monitoring organ pig models Re-infections reached recipient recognize research finding resulting risk SARS-CoV-2 SARS-CoV-2 variant Therapeutics Topic viral infection Viral load virus xenotransplantation. [DOI] 10.1111/xen.12772 PMC 바로가기
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic코로나19 팬데믹 기간 동안 이탈리아 선천성 면역질환 환자의 단클론항체 및 항바이러스제 실생활 데이터Article Published on 2022-07-282022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] Alpha Analysis Antiviral antiviral agent Antiviral agents antiviral drug antiviral drugs Asymptomatic Care circulating Cohort contributed Course COVID-19 COVID-19 pandemic COVID-19 severity disease disease severity duration of viral shedding Effect Efficacy error evaluated Hospital admission Hospitalization hospitalization-risk hospitalizations hospitalized patients ICU admission Immunity immunized Inborn Inborn errors inborn errors of immunity Infection Italian longitudinal lower risk mAbs mitigate monoclonal monoclonal antibodies monoclonal antibody Mortality mRNA vaccine mRNA vaccines offered Patient patients treated performed positive Prevent prophylactic measure prophylactic measures Re-infection Re-infections reduce reduced Reinfection reinfection. reported respond risk Safe SARS-CoV-2 SARS-CoV-2 infected patients SARS-CoV-2 positivity SARS-CoV-2 strains SARS-CoV-2 virus severe COVID-19 severe disease Spectrum Spread Strains therapeutic therapy treated vaccination Vaccinations Viral viral shedding viral strain viral strains widespread [DOI] 10.3389/fimmu.2022.947174 PMC 바로가기 [Article Type] Article
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineagesSARS-CoV-2 오미크론 하위 계통의 기원, 바이러스학적 특징, 면역 회피 및 개입Review Published on 2022-07-192022-09-11 Journal: Signal Transduction and Targeted Therapy [Category] Coronavirus, COVID19(2023년), SARS, 변종, 진단, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 B.1.1.529 benefit breakthrough infections carried caused circulating coronavirus dominant Features global public health Immune escape immune evasion Infection Intervention Mutation Neutralizing antibodies neutralizing antibody omicron Omicron variant origin other variant other variants Re-infection Re-infections SARS-CoV-2 SARS-CoV-2 variants severe acute respiratory syndrome Coronavirus Spike protein Spread Therapeutics Transmissibility vaccination Vaccine variant variants Virological VOCs [DOI] 10.1038/s41392-022-01105-9 PMC 바로가기 [Article Type] Review
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort studySARS-CoV-2의 B.1.1.7(알파) 변이와 비교한 B.1.617.2(델타) 변이로 인한 COVID-19: 전향적 관찰 코호트 연구Observational Study Published on 2022-06-282022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 임상, 진단, [키워드] 1:1 age Alpha B.1.1.7 B.1.617.2 circulating comparison COVID COVID-19 Delta delta variant disease Dyspnoea Effectiveness Efficacy Fever headache hospital hospitalisation illness illness duration individual individuals Infection positive predominant presenting prospective observational cohort Re-infections reduced regions Reinfection Research risk SARS-CoV-2 SARS-CoV-2 strain Seven sore throat Symptom symptom burden symptomatic adult symptomatic adults Symptoms tested Transmission Vaccine variant variants were assessed [DOI] 10.1038/s41598-022-14016-0 PMC 바로가기 [Article Type] Observational Study
Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers예방 접종을 받은 의료 종사자 간의 B.1.617.2 Delta 변이의 전파Article Published on 2022-06-212022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, [키워드] analysed approach B.1.617.2 benefit breakthrough infections Care Computational approaches delta variant described dose eight epidemiological HCW HCWs Health Health care Health care worker health care workers healthcare worker highlight hospital India individual Infection infection control less likelihood measure Patient populations potential for transmission Probability Re-infections recipient reduce reported SARS-CoV-2 sequence Transmission transmissions transmitted vaccination Vaccine viral spread virus genome virus transmission [DOI] 10.1038/s41598-022-14411-7 PMC 바로가기 [Article Type] Article
Athletes’ Mesenchymal Stem Cells Could Be the Best Choice for Cell Therapy in Omicron-Infected Patients운동선수의 중간엽 줄기세포는 오마이크론에 감염된 환자의 세포 치료를 위한 최선의 선택이 될 수 있습니다Article Published on 2022-06-142022-09-11 Journal: Cells [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition alveolar anti-apoptotic Anti-inflammatory antioxidant athlete Breakthrough infection breakthrough infections caused Cell cell survival choice coronavirus COVID-19 Cytokines Defense defense mechanisms effective epithelial cells exercise growth growth rate growth signaling highlight immunomodulatory incidence Inflammation Ischemia mechanism microenvironment Mutation New omicron outcome oxidative stress patients Re-infections reduce reduced respiratory epithelial cell respiratory epithelial cells SARS-CoV-2 secretion sport STEM stem cell Stem cell. stem cells stem-cell therapy suggested Support survival therapy transplantation Treatment Vaccine variant variants [DOI] 10.3390/cells11121926 PMC 바로가기 [Article Type] Article
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations류마티스성 근골격계 질환의 면역억제제 치료는 SARS-CoV-2 감염에 대한 체액 반응의 유발을 억제하지 않고 이펙터 면역 세포 집단을 보존합니다Article Published on 2022-06-102022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 치료법, [키워드] adaptive addition affected Analysis antibody Antibody Response Antibody responses Arthritis B lymphocytes biologic carried Cellular immune response COVID-19 CTLA4 disease disease-modifying anti-rheumatic drug Disease-modifying anti-rheumatic drugs Diseases DMARD drug effector elicit functional humoral Humoral and cellular immune responses immune immune cell populations immune response immune responses immune system immunological Immunosuppressant include individual Inflammatory Inflammatory arthritis inhibitor inhibitors life-threatening Musculoskeletal Neutralizing activity Pathologies Patient patients treated Population presenting provide RBD protein RBD proteins Re-infections response rheumatic musculoskeletal diseases. SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid sustained the antibody response TNF-α Treatment virus [DOI] 10.3389/fimmu.2022.873195 PMC 바로가기 [Article Type] Article
Re-infection in COVID-19: Do we exaggerate our worries?COVID-19의 재감염: 걱정을 과장합니까?Article Published on 2022-06-012022-09-11 Journal: European Journal of Clinical Investigation [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age Chain Reaction confirmed cases coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Critical Critical illness death defined diagnosed diagnosis of COVID-19 evaluated exaggerate female Hospitalization Immunity Mortality mutations Patient patients polymerase chain polymerase chain reaction positive result progression Public Re-infection Re-infections Real-Time Reverse Transcription Polymerase Chain Reaction real-time RT-PCR reported respiratory sample Respiratory samples reverse transcription reverse transcription polymerase chain reaction risk factor Risk factors RT-PCR SARS-CoV-2 severe acute respiratory syndrome Coronavirus Strains Symptoms System Turkey vaccination vaccination schedule Vaccination Status vaccination. variant with COVID-19 [DOI] 10.1111/eci.13767 PMC 바로가기 [Article Type] Article
Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India인도 남부의 의료 종사자 집단에서 COVID-19에 대한 사전 감염 및 예방 접종에 의해 부여된 보호 효과Article Published on 2022-05-202022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI absence Cohort covariate COVID-19 COVID-19 disease Cox proportional hazard Cox proportional hazards model delta variant dose Efficacy examined HCW Health care health care workers healthcare worker Healthcare workers Immune escape incidence Infection infection rate infection rates offered proportional hazards model Protective protective effect provided raise Re-infection Re-infections reported resulting RT-PCR second wave severe disease south India symptomatic symptomatic infection tested vaccination Vaccine vaccine efficacy variant were infected [DOI] 10.1371/journal.pone.0268797 PMC 바로가기 [Article Type] Article
The changing dynamics of neutralizing antibody response within 10 months of SARS-CoV-2 infectionsSARS-CoV-2 감염 후 10개월 이내에 중화 항체 반응의 역학 변화Article Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Analysis average Comorbidity convalescent patient convalescent phase COVID-19 detectable determine discharge disease severity elicited Factor Follow-up Gender hospital humoral Humoral immunity Infection Inpatient investigated laboratory-confirmed long-term immunity majority mild infection mild infections mild patient mild patients multivariate NAb nAb response NAb titer NAb titers NAbs Neutralizing antibodies neutralizing antibodies. neutralizing antibody Neutralizing antibody response not affect parameter Patient predictor prospective cohort protective effect Re-infection Re-infections SARS-CoV-2 SARS-COV-2 infection serum sample serum samples significantly significantly higher the patient titers Virus neutralization was performed [DOI] 10.1002/jmv.27544 PMC 바로가기 [Article Type] Article